Abbas Nasir, Oswald Iain D H, Pulham Colin R
College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan.
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.
Pharmaceutics. 2017 May 16;9(2):16. doi: 10.3390/pharmaceutics9020016.
High-pressure crystallisation has been successfully used as an alternative technique to prepare Form II of a non-steroidal anti-inflammatory drug, mefenamic acid (MA). A single crystal of Form II, denoted as high-pressure Form II, was grown at 0.3 GPa from an ethanolic solution by using a diamond anvil cell. A comparison of the crystal structures shows that the efficient packing of molecules in Form II was enabled by the structural flexibility of MA molecules. Compression studies performed on a single crystal of Form I resulted in a 14% decrease of unit cell volume up to 2.5 GPa. No phase transition was observed up to this pressure. A reconstructive phase transition is required to induce conformational changes in the structure, which was confirmed by the results of crystallisation at high pressure.
高压结晶已成功用作制备非甾体抗炎药甲芬那酸(MA)II型晶型的替代技术。通过使用金刚石对顶砧池,在0.3 GPa下从乙醇溶液中生长出II型单晶,称为高压II型。晶体结构的比较表明,MA分子的结构灵活性使II型分子能够有效堆积。对I型单晶进行的压缩研究表明,在高达2.5 GPa的压力下,晶胞体积减少了14%。在此压力之前未观察到相变。诱导结构构象变化需要重构相变,高压结晶结果证实了这一点。